ECC 2015: Rare Cancer Activities & Highlights
The SIOPE Session, Tackling Rare Cancers Requiring Specialist Care: ERNs, & Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The SIOPE Session, Tackling Rare Cancers Requiring Specialist Care: ERNs, & Scientific Symposium: Bayesian, Adaptive and Rare Disease Designs
Scientists identify a new drug target and demonstrate its effectiveness compared to existing treatments
Providing an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastomarovide an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent glioblastoma
Results of the updated Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group meta-analysis of individual patient data also including recent clinical trials, published in theLancet Oncology
The aim of this workshop is to discuss scientific and regulatory evidence requirements for rare diseases, main challenges and identify possible methodological solutions that could work for this and other very rare cancers.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.